Caldera Medical

Caldera Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $90M

Overview

Caldera Medical is a private, commercial-stage medical device company specializing in minimally invasive surgical products for women's pelvic health, specifically stress urinary incontinence, pelvic organ prolapse, and hysteroscopic procedures. The company differentiates itself through a patient-centric culture, a commitment to physician education, and the largest humanitarian program in women's health, aiming to treat one million underserved women by 2027. As the self-described fastest-growing women's health company for the past three years, Caldera leverages surgeon feedback for product improvement and maintains a portfolio of trusted, advanced solutions. Its headquarters are in Agoura Hills, California.

Women's HealthUrogynecologyGynecology

Technology Platform

Portfolio of minimally invasive surgical medical devices for treating Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse (POP), and performing hysteroscopic tissue removal (e.g., for polyps and fibroids).

Funding History

4
Total raised:$90M
Series B$35M
Series B$25M
Series A$20M
Series A$10M

Opportunities

The large and growing global prevalence of SUI and POP, coupled with increasing treatment acceptance, provides a substantial addressable market.
The unique Global Humanitarian Program offers significant brand differentiation, builds provider loyalty in emerging regions, and aligns with growing ESG (Environmental, Social, and Governance) investment criteria.

Risk Factors

The company operates in a pelvic mesh market with a legacy of major product liability litigation, posing significant legal and reputational risk.
It also faces intense competition from large, established medical device corporations with greater resources for R&D and marketing.

Competitive Landscape

Caldera competes in the women's health medical device space against large, diversified medtech giants like Boston Scientific, Coloplast, and Johnson & Johnson's Ethicon division. Its competitive strategy relies on a focused product portfolio, strong surgeon relationships, a mission-driven culture, and a unique humanitarian program rather than competing solely on scale or price.